Cargando…

Comparison of 24-h Urine Protein, Urine Albumin-to-Creatinine Ratio, and Protein-to-Creatinine Ratio in IgA Nephropathy

BACKGROUND: Proteinuria is a strong risk factor for renal outcomes in IgA nephropathy. Random urine protein-to-creatinine ratio (PCR), random albumin-to-creatinine ratio (ACR), and 24-h urine protein excretion (24-h UP) have been widely used in clinical practice. However, the measurement which is th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Guizhen, Cheng, Jun, Li, Heng, Li, Xiayu, Chen, Jianghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918683/
https://www.ncbi.nlm.nih.gov/pubmed/35295594
http://dx.doi.org/10.3389/fmed.2022.809245
_version_ 1784668784435396608
author Yu, Guizhen
Cheng, Jun
Li, Heng
Li, Xiayu
Chen, Jianghua
author_facet Yu, Guizhen
Cheng, Jun
Li, Heng
Li, Xiayu
Chen, Jianghua
author_sort Yu, Guizhen
collection PubMed
description BACKGROUND: Proteinuria is a strong risk factor for renal outcomes in IgA nephropathy. Random urine protein-to-creatinine ratio (PCR), random albumin-to-creatinine ratio (ACR), and 24-h urine protein excretion (24-h UP) have been widely used in clinical practice. However, the measurement which is the best predictor of long-term renal outcomes remains controversial. This study aimed to compare the three measurements in IgA nephropathy. METHODS: We conducted a retrospective study of 766 patients with IgA nephropathy. The associations among baseline ACR, PCR, and 24-h UP with chronic kidney disease (CKD) progression event, defined as 50% estimated glomerular filtration rate (eGFR) decline or end stage kidney disease (ESKD), were tested and compared. RESULTS: In this study, ACR, PCR, and 24-h UP showed high correlation (r = 0.671–0.847, P < 0.001). After a median follow-up of 29.88 (14.65–51.65) months, 51 (6.66%) patients reached the CKD progression event. In univariate analysis, ACR performed better in predicting the prognosis of IgA nephropathy, with a higher area under the receiver operating curve (ROC) curve than PCR and 24-h UP. After adjustment for traditional risk factors, ACR was most associated with composite CKD progression event [per log-transformed ACR, hazard ratio (HR): 2.82; 95% (95% CI): 1.31–6.08; P = 0.008]. CONCLUSIONS: In IgA nephropathy, ACR, PCR, and 24-h UP had a high correlation. ACR performed better in predicting the prognosis of IgA nephropathy.
format Online
Article
Text
id pubmed-8918683
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89186832022-03-15 Comparison of 24-h Urine Protein, Urine Albumin-to-Creatinine Ratio, and Protein-to-Creatinine Ratio in IgA Nephropathy Yu, Guizhen Cheng, Jun Li, Heng Li, Xiayu Chen, Jianghua Front Med (Lausanne) Medicine BACKGROUND: Proteinuria is a strong risk factor for renal outcomes in IgA nephropathy. Random urine protein-to-creatinine ratio (PCR), random albumin-to-creatinine ratio (ACR), and 24-h urine protein excretion (24-h UP) have been widely used in clinical practice. However, the measurement which is the best predictor of long-term renal outcomes remains controversial. This study aimed to compare the three measurements in IgA nephropathy. METHODS: We conducted a retrospective study of 766 patients with IgA nephropathy. The associations among baseline ACR, PCR, and 24-h UP with chronic kidney disease (CKD) progression event, defined as 50% estimated glomerular filtration rate (eGFR) decline or end stage kidney disease (ESKD), were tested and compared. RESULTS: In this study, ACR, PCR, and 24-h UP showed high correlation (r = 0.671–0.847, P < 0.001). After a median follow-up of 29.88 (14.65–51.65) months, 51 (6.66%) patients reached the CKD progression event. In univariate analysis, ACR performed better in predicting the prognosis of IgA nephropathy, with a higher area under the receiver operating curve (ROC) curve than PCR and 24-h UP. After adjustment for traditional risk factors, ACR was most associated with composite CKD progression event [per log-transformed ACR, hazard ratio (HR): 2.82; 95% (95% CI): 1.31–6.08; P = 0.008]. CONCLUSIONS: In IgA nephropathy, ACR, PCR, and 24-h UP had a high correlation. ACR performed better in predicting the prognosis of IgA nephropathy. Frontiers Media S.A. 2022-02-28 /pmc/articles/PMC8918683/ /pubmed/35295594 http://dx.doi.org/10.3389/fmed.2022.809245 Text en Copyright © 2022 Yu, Cheng, Li, Li and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Yu, Guizhen
Cheng, Jun
Li, Heng
Li, Xiayu
Chen, Jianghua
Comparison of 24-h Urine Protein, Urine Albumin-to-Creatinine Ratio, and Protein-to-Creatinine Ratio in IgA Nephropathy
title Comparison of 24-h Urine Protein, Urine Albumin-to-Creatinine Ratio, and Protein-to-Creatinine Ratio in IgA Nephropathy
title_full Comparison of 24-h Urine Protein, Urine Albumin-to-Creatinine Ratio, and Protein-to-Creatinine Ratio in IgA Nephropathy
title_fullStr Comparison of 24-h Urine Protein, Urine Albumin-to-Creatinine Ratio, and Protein-to-Creatinine Ratio in IgA Nephropathy
title_full_unstemmed Comparison of 24-h Urine Protein, Urine Albumin-to-Creatinine Ratio, and Protein-to-Creatinine Ratio in IgA Nephropathy
title_short Comparison of 24-h Urine Protein, Urine Albumin-to-Creatinine Ratio, and Protein-to-Creatinine Ratio in IgA Nephropathy
title_sort comparison of 24-h urine protein, urine albumin-to-creatinine ratio, and protein-to-creatinine ratio in iga nephropathy
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918683/
https://www.ncbi.nlm.nih.gov/pubmed/35295594
http://dx.doi.org/10.3389/fmed.2022.809245
work_keys_str_mv AT yuguizhen comparisonof24hurineproteinurinealbumintocreatinineratioandproteintocreatinineratioiniganephropathy
AT chengjun comparisonof24hurineproteinurinealbumintocreatinineratioandproteintocreatinineratioiniganephropathy
AT liheng comparisonof24hurineproteinurinealbumintocreatinineratioandproteintocreatinineratioiniganephropathy
AT lixiayu comparisonof24hurineproteinurinealbumintocreatinineratioandproteintocreatinineratioiniganephropathy
AT chenjianghua comparisonof24hurineproteinurinealbumintocreatinineratioandproteintocreatinineratioiniganephropathy